(-0.04%) 5 305.81 points
(0.08%) 39 838 points
(-0.19%) 16 762 points
(-0.86%) $79.11
(-1.93%) $2.70
(-0.36%) $2 429.60
(-0.51%) $32.26
(0.10%) $1 064.80
(0.13%) $0.922
(-0.23%) $10.67
(-0.02%) $0.787
(-0.19%) $90.51
Live Chart Being Loaded With Signals
ENDRA Life Sciences Inc. develops technology for improving the capabilities of clinical diagnostic ultrasound. The company develops thermo-acoustic enhanced ultrasound technology that transmits sound waves, which bounce off tissues, organs, and blood in the body for use in the treatment of nonalcoholic fatty liver disease, as well as in temperature monitoring of thermoablative surgery, vascular imaging, and tissue perfusion...
Stats | |
---|---|
本日の出来高 | 52 398.00 |
平均出来高 | 186 909 |
時価総額 | 3.61M |
EPS | $0 ( 2024-05-14 ) |
次の収益日 | ( $-0.270 ) 2024-08-12 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -0.210 |
ATR14 | $0.00200 (0.61%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-01-02 | Basenese Lou | Buy | 600 | Stock Options |
2024-01-02 | Harsh Michael | Buy | 600 | Stock Options |
2024-01-02 | Digiandomenico Anthony | Buy | 600 | Stock Options |
2024-01-02 | Tokman Alexander Y | Buy | 600 | Stock Options |
2023-05-18 | Thornton Michael Milos | Buy | 15 000 | Common Stock |
INSIDER POWER |
---|
100.00 |
Last 100 transactions |
Buy: 3 706 167 | Sell: 432 712 |
ボリューム 相関
ENDRA Life Sciences Inc 相関
10 最も負の相関 | |
---|---|
KEQU | -0.944 |
EML | -0.93 |
IVCB | -0.929 |
SWAV | -0.929 |
FUSN | -0.927 |
CDXC | -0.907 |
LABP | -0.907 |
PESI | -0.905 |
BCSA | -0.904 |
IMPPP | -0.904 |
知っていましたか?
相関は、2つの変数間の関係を説明する統計的指標です。相関係数は-1から1までの値を取り、-1は完全な負の相関(1つの変数が増加すると、もう一方は減少する)、1は完全な正の相関(1つの変数が増加すると、もう一方も増加する)、0は相関がないことを示します(変数間に関係がない)。
相関は、株式だけでなく、どの2つの変数間の関係にも適用できます。これは、金融、経済学、心理学などの分野で一般的に使用されています。
ENDRA Life Sciences Inc 相関 - 通貨/商品
ENDRA Life Sciences Inc 財務諸表
Annual | 2023 |
収益: | $0 |
総利益: | $-275 451 (0.00 %) |
EPS: | $-1.580 |
FY | 2023 |
収益: | $0 |
総利益: | $-275 451 (0.00 %) |
EPS: | $-1.580 |
FY | 2022 |
収益: | $0 |
総利益: | $-234 258 (0.00 %) |
EPS: | $-4.57 |
FY | 2021 |
収益: | $0.00 |
総利益: | $0.00 (0.00 %) |
EPS: | $-11.83 |
Financial Reports:
No articles found.
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
ENDRA Life Sciences Inc
ENDRA Life Sciences Inc. develops technology for improving the capabilities of clinical diagnostic ultrasound. The company develops thermo-acoustic enhanced ultrasound technology that transmits sound waves, which bounce off tissues, organs, and blood in the body for use in the treatment of nonalcoholic fatty liver disease, as well as in temperature monitoring of thermoablative surgery, vascular imaging, and tissue perfusion. It also offers diagnostic imaging technologies, such as computed tomography, magnetic resonance imaging, and ultrasound that allow physicians to look inside a person's body to guide treatment or gather information about medical conditions, such as broken bones, cancers, signs of heart disease, or internal bleeding. The company has a collaborative research agreement with General Electric Company. ENDRA Life Sciences Inc. was incorporated in 2007 and is based in Ann Arbor, Michigan.
について ライブシグナル
このページで提示されるライブシグナルは、NA を買う時や売る時を判断するのに役立ちます。シグナルには1分以上の遅延があります。市場シグナルには誤りやミスの可能性があるため、ライブ取引シグナルは決定的ではなく、getagraph.comはこれらのシグナルに基づく任意の行動について責任を負いません。詳細については、利用規約で説明されているように、技術分析指標に基づいています。